New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Amicus Therapeutics, Inc.
FOLD
Shape
US Flag

NASDAQ

3B

Biotechnology

Next Earning date - 08 May 2025

3B

Biotechnology

Next Earning date - 08 May 2025

9.01USD

Shape-0.07 ( -0.83%)
Market Closed (as of Mar 21, 20:00 EDT)
favorite-chart

Relative Strenght

24
favorite-chart

Volume Buzz

31%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

29%

Quote Panel

Shape
Updated March 25, 2025
1W -5.54 % 1M -3.77 % 3M -11.05 % 1Y -23.97 %

Key Metrics

Shape
  • Market Cap

    2.67B


  • Shares Outstanding

    307.24M


  • Share in Float

    296.87M


  • Dividende

    0


  • Earning Date

    08 May 2025


  • Price Target

    8.69


  • Average Volume

    2.30M


  • Beta

    0.688


  • Range

    8.55-12.65


  • Industry

    Biotechnology


  • Website

    https://amicusrx.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

FOLD

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$631M

Shape322%

2025-Revenue

$0.03

Shape-47%

2025-EPS

$300M

Shape-1468%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Jefferies

initialise

Previous: Not converted

2024-09-06

Now: Buy

Wells Fargo

initialise

Previous: Not converted

2024-05-30

Now: Overweight

Guggenheim

upgrade

Previous: Not converted

2024-05-14

Now: Buy

Morgan Stanley

upgrade

Previous: Not converted

2023-12-19

Now: Overweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-0.18
vs -0.30

Q2.23

arrow
arrow

N/A

-0.15
vs -0.21

Q3.23

arrow
arrow

N/A

-0.07
vs -0.12

Q4.23

arrow
arrow

N/A

-0.11
vs -0.19

Q1.24

arrow
arrow

N/A

-0.02
vs -0.18

Q2.24

arrow
arrow

+140%

0.06
vs -0.15

Q3.24

arrow
arrow

+243%

0.1
vs -0.07

Q4.24

arrow
arrow

N/A

NA
vs -0.11

Q1.25

arrow
arrow

N/A

-0.05
vs -0.02

Q2.25

arrow
arrow

N/A

-0.01
vs 0.06

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

+10%

86.3M  vs 78.7M

Q2.23

arrow
arrow

+17%

94.5M  vs 80.7M

Q3.23

arrow
arrow

+27%

103.5M  vs 81.7M

Q4.23

arrow
arrow

+31%

115.1M  vs 88.1M

Q1.24

arrow
arrow

+28%

110.4M  vs 86.3M

Q2.24

arrow
arrow

+34%

126.7M  vs 94.5M

Q3.24

arrow
arrow

+37%

141.5M  vs 103.5M

Q4.24

arrow
arrow

+30%

149.7M  vs 115.1M

Q1.25

arrow
arrow

+24%

136.6M  vs 110.4M

Q2.25

arrow
arrow

+19%

150.6M  vs 126.7M

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

-52%

-0.52
vs -0.45

Q2.23

arrow
arrow

-39%

-0.39
vs -0.52

Q3.23

arrow
arrow

-16%

-0.16
vs -0.39

Q4.23

arrow
arrow

-21%

-0.21
vs -0.16

Q1.24

arrow
arrow

-37%

-0.37
vs -0.21

Q2.24

arrow
arrow

-12%

-0.12
vs -0.37

Q3.24

arrow
arrow

-4%

-0.04
vs -0.12

Q4.24

arrow
arrow

+8%

0.08
vs -0.04

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

232

232
vs 242

-4%

Q2.23

arrow
arrow

227

227
vs 232

-2%

Q3.23

arrow
arrow

246

246
vs 227

8%

Q4.23

arrow
arrow

244

244
vs 246

-1%

Q1.24

arrow
arrow

264

264
vs 244

8%

Q2.24

arrow
arrow

267

267
vs 264

1%

Q3.24

arrow
arrow

302

302
vs 267

13%

Q4.24

arrow
arrow

300

300
vs 302

-1%

Earnings Growth

Latest News